Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer
Clinical trial NCT03192059 · COMPLETED
Trial details
- NCT number
- NCT03192059
- Sponsor
- University Hospital, Ghent
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2021-06-30
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.